Blockage of CR1 prevents activation of rodent microglia

Neurobiology of Disease

Volumn 54, Issue , 2013, Pages 139-149

  Crehan, Helen ^a,b   Hardy, John ^b   Pocock, Jennifer ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

A 1 42; Alzheimer's disease; Complement receptor 1; Cytokine; Lipopolysaccharide; Microglia; Phagocytosis

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; COMPLEMENT COMPONENT C3B RECEPTOR; INTERLEUKIN 1BETA; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; MICROGLIA; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BRAIN; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MICROGLIA; NERVE DEGENERATION; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTORS, COMPLEMENT; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84876340047     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.02.003     Document Type: Article

References (69)

1. Arroyo D.S., Soria J.A., Gaviglio E.A., Rodrizuez-Galan M.C., Iribarren P. Toll-like receptors are key players in neurodegeneration. Int. Immunopharmacol. 2011, 11:1415-1421.
2. Barth P., Schunter F., Wilms K., Waller H.D., Wernet P. Classification of leukemic cells by Ia alloantigens and complement receptors. Surface probes for cell differentiation. Bibl. Haematol. 1978, 45:124-130.
3. Brouwers N., Van Cauwenberghe C., Engelborghs S., Lambert J.C., Bettens K., Le Bastard N., Pasquier F., Montoya A.G., Peeters K., Mattheijssens M., Vandenberghe R., De Deyn P.P., Cruts M., Amouyel P., Sleegers K., Van Broeckhoven C. Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites. Mol. Psychiatry 2011, (Mar 15. [Epub ahead of print]).
4. Chibnik L.B., Shulman J.M., Leurgans S.E., Schneider J.A., Wilson R.S., Tran D., Aubin C., Buchman A.S., Heward C.B., Myers A.J., Hardy J.A., Huentelman M.J., Corneveaux J.J., Reiman E.M., Evans D.A., Bennett D.A., De Jager P.L. CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann. Neurol. 2011, 69(3):560-569. (Mar).
5. Chow J.C., Young D.W., Golenbock D.T., Christ W.J., Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 1999, 274(16):10689-10692. (Apr 16).
6. Crehan H., Holton P., Wray S., Pocock J., Guerreiro R., Hardy J. Complement receptor 1 (CR1) and Alzheimer's disease. Immunobiology 2012, 217(2):244-250. (Feb).
7. Davenport C.M., Sevastou I.G., Hooper C., Pocock J.M. Inhibiting p53 pathways in microglia attenuates microglial-evoked neurotoxicity following exposure to Alzheimer peptides. J. Neurochem. 2010, 112(2):552-563. (Jan).
8. Di Bona D., Plaia A., Vasto S., Cavallone L., Lescai F., Franceschi C., Licastro F., Colonna-Romano G., Lio D., Candore G., Caruso C. Association between the interleukin-1beta polymorphisms and Alzheimer's disease: a systematic review and meta-analysis. Brain Res. Rev. 2008, 59(1):155-163. (Nov).
9. Di Bona D., Candore G., Franceschi C., Licastro F., Colonna-Romano G., Cammà C., Lio D., Caruso C. Systematic review by meta-analyses on the possible role of TNF-alpha polymorphisms in association with Alzheimer's disease. Brain Res. Rev. 2009, 61(2):60-68. (Oct).
10. Fang F., Lue L.F., Yan S., Xu H., Luddy J.S., Chen D., Walker D.G., Stern D.M., Yan S., Schmidt A.M., Chen J.X., Yan S.S. RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease. FASEB J. 2010, 24(4):1043-1055. (Apr).
11. Färber K., Cheung G., Mitchell D., Wallis R., Weihe E., Schwaeble W., Kettenmann H. C1q, the recognition subcomponent of the classical pathway of complement, drives microglial activation. J. Neurosci. Res. 2009, 87(3):644-652. (2009 Feb 15).
12. Fetler L., Amigorena S. Neuroscience. Brain under surveillance: the microglia patrol. Science 2005, 309(5733):392-393. (Jul 15).
13. Gessler P., Dahinden C. Increased respiratory burst and increased expression of complement receptor-3 (CD11b/CD18) and of IL-8 receptor-A in neutrophil granulocytes from newborns after vaginal delivery. Biol. Neonate 2003, 83(2):107-112.
14. Guerreiro R.J., Gustafson D.R., Hardy J. The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE. Neurobiol. Aging 2012, 33(3):437-456. (Mar).
15. Hirrlinger J., Gutterer J.M., Kussmaul L., Hamprecht B., Dringen R. Microglial cells in culture express a prominent glutathione system for the defense against reactive oxygen species. Dev. Neurosci. 2000, 22(5-6):384-392. (Sep-Dec).
16. Hollingworth P., Harold D., Sims R., Gerrish A., Lambert J.C., Carrasquillo M.M., Abraham R., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Jones N., Stretton A., Thomas C., Richards A., Ivanov D., Widdowson C., Chapman J., Lovestone S., Powell J., Proitsi P., Lupton M.K., Brayne C., Rubinsztein D.C., Gill M., Lawlor B., Lynch A., Brown K.S., Passmore P.A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A.D., Beaumont H., Warden D., Wilcock G., Love S., Kehoe P.G., Hooper N.M., Vardy E.R., Hardy J., Mead S., Fox N.C., Rossor M., Collinge J., Maier W., Jessen F., Rüther E., Schürmann B., Heun R., Kölsch H., van den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frölich L., Hampel H., Gallacher J., Hüll M., Rujescu D., Giegling I., Goate A.M., Kauwe J.S., Cruchaga C., Nowotny P., Morris J.C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Livingston G., Bass N.J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C.E., Tsolaki M., Singleton A.B., Guerreiro R., Mühleisen T.W., Nöthen M.M., Moebus S., Jöckel K.H., Klopp N., Wichmann H.E., Pankratz V.S., Sando S.B., Aasly J.O., Barcikowska M., Wszolek Z.K., Dickson D.W., Graff-Radford N.R., Petersen R.C., Alzheimer's Disease Neuroimaging Initiative, van Duijn C.M., Breteler M.M., Ikram M.A., DeStefano A.L., Fitzpatrick A.L., Lopez O., Launer L.J., Seshadri S., CHARGE consortium, Berr C., Campion D., Epelbaum J., Dartigues J.F., Tzourio C., Alpérovitch A., Lathrop M., EADI1 consortium, Feulner T.M., Friedrich P., Riehle C., Krawczak M., Schreiber S., Mayhaus M., Nicolhaus S., Wagenpfeil S., Steinberg S., Stefansson H., Stefansson K., Snaedal J., Björnsson S., Jonsson P.V., Chouraki V., Genier-Boley B., Hiltunen M., Soininen H., Combarros O., Zelenika D., Delepine M., Bullido M.J., Pasquier F., Mateo I., Frank-Garcia A., Porcellini E., Hanon O., Coto E., Alvarez V., Bosco P., Siciliano G., Mancuso M., Panza F., Solfrizzi V., Nacmias B., Sorbi S., Bossù P., Piccardi P., Arosio B., Annoni G., Seripa D., Pilotto A., Scarpini E., Galimberti D., Brice A., Hannequin D., Licastro F., Jones L., Holmans P.A., Jonsson T., Riemenschneider M., Morgan K., Younkin S.G., Owen M.J., O'Donovan M., Amouyel P., Williams J. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat. Genet. 2011, 43(5):429-435. (May).
17. Hoogerwerf M., Weening R.S., Hack C.E., Roos D. Complement fragments C3b and iC3b coupled to latex induce a respiratory burst in human neutrophils. Mol. Immunol. 1990, 27(2):159-167. (Feb).
18. Hooper C., Fry V.A., Sevastou I.G., Pocock J.M. (a). Scavenger receptor control of chromogranin A-induced microglial stress and neurotoxic cascades. FEBS Lett. 2009, 583(21):3461-3466. (Nov 3).
19. Hooper C., Pinteaux-Jones F., Fry V.A., Sevastou I.G., Baker D., Heales S.J. Pocock JM (b) Differential effects if albumin on microglia and macrophages; implications for neurodegeneration following blood-brain barrier damage. J. Neurochem. 2009, 109(3):694-705. (May).
20. Jaconson A.C., Weis J.H. Comparative functional evolution of human and mouse CR1 and CR2. J. Immunol. 2008, 181:2953-2959.
21. Jones L., Holmans P.A., Hamshere M.L., Harold D., Moskvina V., Ivanov D., Pocklington A., Abraham R., Hollingworth P., Sims R., Gerrish A., Pahwa J.S., Jones N., Stretton A., Morgan A.R., Lovestone S., Powell J., Proitsi P., Lupton M.K., Brayne C., Rubinsztein D.C., Gill M., Lawlor B., Lynch A., Morgan K., Brown K.S., Passmore P.A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A.D., Love S., Kehoe P.G., Mead S., Fox N., Rossor M., Collinge J., Maier W., Jessen F., Schürmann B., Heun R., Kölsch H., van den Bussche H., Heuser I., Peters O., Kornhuber J., Wiltfang J., Dichgans M., Frölich L., Hampel H., Hüll M., Rujescu D., Goate A.M., Kauwe J.S., Cruchaga C., Nowotny P., Morris J.C., Mayo K., Livingston G., Bass N.J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C.E., Singleton A.B., Guerreiro R., Mühleisen T.W., Nöthen M.M., Moebus S., Jöckel K.H., Klopp N., Wichmann H.E., Rüther E., Carrasquillo M.M., Pankratz V.S., Younkin S.G., Hardy J., O'Donovan M.C., Owen M.J., Williams J. Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One 2010, 5(11):e13950. (Nov 15).
22. Kavai M. Immune complex clearance by complement receptor type 1 in SLE. Autoimmun. Rev. 2008, 8(2):160-164. (Dec).
23. Keelan J., Allen N.J., Antcliffe D., Pal S., Duchen M.R. Quantitative imaging of glutathione in hippocampal neurons and glia in culture using monochlorobimane. J. Neurosci. Res. 2001, 66(5):873-884. (Dec 1).
24. Killick R., Hughes T.R., Morgan B.P., Lovestone S. Deletion of Crry, the murine ortholog of the sporadic Alzheimer's disease risk gene CR1, impacts tau phosphorylation and brain CFH. Neurosci. Lett. 2012, (12):1465-1466. (Nov 12. doi:pii: S0304-3940).
25. Kim C.Y., Lee C., Park G.H., Jang J.H. Neuroprotective effect of epigallocatechin-3-gallate against beta-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity. Arch. Pharm. Res. 2009, 32(6):869-881. (Jun).
26. Kingham P.J., Pocock J.M. Microglial apoptosis induced by chromogranin A is mediated by mitochondrial depolarisation and the permeability transition but not by cytochrome c release. J. Neurochem. 2000, 74(4):1452-1462. (Apr).
27. Koenigsknecht J., Landreth G. Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism. J. Neurosci. 2004, 24(44):9838-9846.
28. Köhl J. The role of complement in danger sensing and transmission. Immunol. Res. 2006, 34(2):157-176.
29. Kurtz C.B., O'Toole E., Christensen S.M., Weis J.H. The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J. Immunol. 1990, 144(9):3581-3591. (May 1).
30. Kvarstein B. The effect of temperature, metabolic inhibitors, and EDTA on phagocytosis of polystyrene latex particles by human leucocytes. Scand. J. Clin. Lab. Invest. 1969, 24(3):271-277. (Oct).
31. Lambert J.C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M., Combarros O., Zelenika D., Bullido M.J., Tavernier B., Letenneur L., Bettens K., Berr C., Pasquier F., Fiévet N., Barberger-Gateau P., Engelborghs S., De Deyn P., Mateo I., Franck A., Helisalmi S., Porcellini E., Hanon O., European Alzheimer's Disease Initiative Investigators, de Pancorbo M.M., Lendon C., Dufouil C., Jaillard C., Seripa D., Galimberti D., Hannequin D., Licastro F., Soininen H., Ritchie K., Blanché H., Dartigues J.F., Tzourio C., Gut I., Van Broeckhoven C., Alpérovitch A., Lathrop M., Amouyel P. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 2009, 41(10):1094-1099. (Oct).
32. Lautner R., Mattsson N., Schöll M., Augutis K., Blennow K., Olsson B., Zetterberg H. Biomarkers for microglial activation in Alzheimer's disease. Int. J. Alzheimers Dis. 2011, 939426. Electronic publication ahead of print 2011 Nov 1. 10.4061/2011/939426.
33. Le W., Rowe D., Xie W., Ortiz I., He Y., Appel S.H. Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease. J. Neurosci. 2001, 21(21):8447-8455. (Nov 1).
34. Li J., Wang J.P., Ghiran I., Cerny A., Szalai A.J., Briles D.E., Finberg R.W. Complement receptor 1 expression on mouse erythrocytes mediates clearance of Streptococcus pneumoniae by immune adherence. Infect. Immun. 2010, 78(7):3129-3135. (Jul).
35. Lien E., Means T.K., Heine H., Yoshimura A., Kusumoto S., Fukase K., Fenton M.J., Oikawa M., Qureshi N., Monks B., Finberg R.W., Ingalls R.R., Golenbock D.T. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 2000, 105(4):497-504. (Feb).
36. Mawuenyega K.G., Sigurdson W., Ovod V., Munsell L., Kasten T., Morris J.C., Yarasheski K.E., Bateman R.J. Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science 2010, 330(6012):1774. (Dec 24).
37. McGeer P.L., McGeer E.G. The possible role of complement activation in Alzheimer disease. Trends Mol. Med. 2002, 8(11):519-523. (Nov).
38. McGeer P.L., Itagaki S., Tago H., McGeer E.G. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci. Lett. 1987, 79(1-2):195-200. (Aug 18).
39. McGeer P.L., Akiyama H., Itagaki S., McGeer E.G. Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci. Lett. 1989, 107(1-3):341-346. (Dec 15).
40. Mead E.L., Mosley A., Eaton S., Dobson L., Heales S.J., Pocock J.M. Microglial neurotransmitter receptors trigger superoxide production in microglia; consequences for microglial-neuronal interactions. J. Neurochem. 2012, 121(2):287-301. (Apr).
41. Molina H., Kinoshita T., Inoue K., Carel J.C., Holers V.M. A molecular and immunochemical characterization of mouse CR2. Evidence for a single gene model of mouse complement receptors 1 and 2. J. Immunol. 1990, 145(9):2974-2983. (Nov 1).
42. Mollnes T.E., Song W.C., Lambris J.D. Complement in inflammatory tissue damage and disease. Trends Immunol. 2002, 23(2):61-64. (Feb).
43. Morales I., Farías G., Maccioni R.B. Neuroimmunomodulation in the pathogenesis of Alzheimer's disease. Neuroimmunomodulation 2010, 17(3):202-204.
44. Naj A.C., Jun G., Beecham G.W., Wang L.S., Vardarajan B.N., Buros J., Gallins P.J., Buxbaum J.D., Jarvik G.P., Crane P.K., Larson E.B., Bird T.D., Boeve B.F., Graff-Radford N.R., De Jager P.L., Evans D., Schneider J.A., Carrasquillo M.M., Ertekin-Taner N., Younkin S.G., Cruchaga C., Kauwe J.S., Nowotny P., Kramer P., Hardy J., Huentelman M.J., Myers A.J., Barmada M.M., Demirci F.Y., Baldwin C.T., Green R.C., Rogaeva E., St George-Hyslop P., Arnold S.E., Barber R., Beach T., Bigio E.H., Bowen J.D., Boxer A., Burke J.R., Cairns N.J., Carlson C.S., Carney R.M., Carroll S.L., Chui H.C., Clark D.G., Corneveaux J., Cotman C.W., Cummings J.L., DeCarli C., DeKosky S.T., Diaz-Arrastia R., Dick M., Dickson D.W., Ellis W.G., Faber K.M., Fallon K.B., Farlow M.R., Ferris S., Frosch M.P., Galasko D.R., Ganguli M., Gearing M., Geschwind D.H., Ghetti B., Gilbert J.R., Gilman S., Giordani B., Glass J.D., Growdon J.H., Hamilton R.L., Harrell L.E., Head E., Honig L.S., Hulette C.M., Hyman B.T., Jicha G.A., Jin L.W., Johnson N., Karlawish J., Karydas A., Kaye J.A., Kim R., Koo E.H., Kowall N.W., Lah J.J., Levey A.I., Lieberman A.P., Lopez O.L., Mack W.J., Marson D.C., Martiniuk F., Mash D.C., Masliah E., McCormick W.C., McCurry S.M., McDavid A.N., McKee A.C., Mesulam M., Miller B.L., Miller C.A., Miller J.W., Parisi J.E., Perl D.P., Peskind E., Petersen R.C., Poon W.W., Quinn J.F., Rajbhandary R.A., Raskind M., Reisberg B., Ringman J.M., Roberson E.D., Rosenberg R.N., Sano M., Schneider L.S., Seeley W., Shelanski M.L., Slifer M.A., Smith C.D., Sonnen J.A., Spina S., Stern R.A., Tanzi R.E., Trojanowski J.Q., Troncoso J.C., Van Deerlin V.M., Vinters H.V., Vonsattel J.P., Weintraub S., Welsh-Bohmer K.A., Williamson J., Woltjer R.L., Cantwell L.B., Dombroski B.A., Beekly D., Lunetta K.L., Martin E.R., Kamboh M.I., Saykin A.J., Reiman E.M., Bennett D.A., Morris J.C., Montine T.J., Goate A.M., Blacker D., Tsuang D.W., Hakonarson H., Kukull W.A., Foroud T.M., Haines J.L., Mayeux R., Pericak-Vance M.A., Farrer L.A., Schellenberg G.D. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat. Genet. 2011, 43(5):436-441. May.
45. Neher J.J., Neniskyte U., Zhao J.W., Bal-Price A., Tolkovsky A.M., Brown G.C. Inhibition of microglial phagocytosis is sufficient to prevent inflammatory neuronal death. J. Immunol. 2011, 186(8):4973-4983. (Apr 15).
46. Odhiambo C.O., Otieno W., Adhiambo C., Odera M.M., Stoute J.A. Increased deposition of C3b on red cells with low CR1 and CD55 in a malaria-endemic region of western Kenya: implications for the development of severe anemia. BMC Med. 2008, 6:23. (Aug 21).
47. Ogle J.D., Noel J.G., Sramkoski R.M., Ogle C.K., Alexander J.W. The effects of cytokines, platelet activating factor, and arachidonate metabolites on C3b receptor (CR1, CD35) expression and phagocytosis by neutrophils. Cytokine 1990, 2(6):447-455. (Nov).
48. Perlmutter L.S., Scott S.A., Barrón E., Chui H.C. MHC class II-positive microglia inhuman brain: association with Alzheimer lesions. J. Neurosci. Res. 1992, 33(4):549-558. (Dec, Erratum in: J Neurosci Res. 35(3):346).
49. Perricone C., De Carolis C., Giacomelli R., Greco E., Cipriani P., Ballanti E., Novelli L., Perricone R. Inhibition of the complement system by glutathione: molecular mechanisms and potential therapeutic implications. Int. J. Immunopathol. Pharmacol. 2011, 24(1):63-68. (Jan-Mar).
50. Peterson P.K., Verhoef J., Quie P.G. Influence of temperature on opsonization and phagocytosis of staphylococci. Infect. Immun. 1977, 15(1):175-179. (Jan).
51. Piers T.M., Heales S.J., Pocock J.M. Positive allosteric modulation of metabotropic glutamate receptor 5 down-regulates fibrinogen-activated microglia providing neuronal protection. Neurosci. Lett. 2011, 505(2):140-145. (Nov 14).
52. Pinteaux-Jones F., Sevastou I.G., Fry V.A., Heales S., Baker D., Pocock J.M. Myelin-induced microglial neurotoxicity can be controlled by microglial metabotropic glutamate receptors. J. Neurochem. 2008, 106(1):442-454. (Jul).
53. Ploemen J.H., van Ommen B., Bogaards J.J., van Bladeren P.J. Ethacrynic acid and its glutathione conjugate as inhibitors of glutathione S-transferases. Xenobiotica 1993, 23(8):913-923. (Aug).
54. Pratten M.K., Lloyd J.B. Phagocytic uptake of latex beads by rat peritoneal macrophages: comparison of morphological and radiochemical assay methods. Biosci. Rep. 1984, 4(6):497-504. (June).
55. Pratten M.K., Lloyd J.B. Pinocytosis and phagocytosis: the effect of size of a particulate substrate on its mode of capture by rat peritoneal macrophages cultured in vitro. Biochim Biophys Acta 1986, 881(3):307-313.
56. Rogers J., Cooper N.R., Webster S., Schultz J., McGeer P.L., Styren S.D., Civin W.H., Brachova L., Bradt B., Ward P., et al. Complement activation by beta-amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 1992, 89(21):10016-10020. (Nov 1).
57. Sheng J.G., Bora S.H., Xu G., Borchelt D.R., Price D.L., Koliatsos V.E. Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice. Neurobiol. Dis. 2003, 14(1):133-145. (Oct).
58. Smith J.A., Das A., Ray S.K., Banik N.L. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res. Bull. 2012, 87(1):10-20. (Jan 4).
59. Stefanska J., Pawliczak R. Apocynin: molecular aptitudes. Mediators Inflamm. 2008, 2008:106507. (Epub 2008 Dec 2. Review.).
60. d prevents amyloid-β oligomer neurotoxicity. J. Neurosci. 2008, 28(20):5149-5158.
61. Taylor D.L., Diemel L.T., Pocock J.M. Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity. J. Neurosci. 2003, 23(6):2150-2160.
62. Taylor D.L., Jones F., Kubota E.S., Pocock J.M. Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand. J. Neurosci. 2005, 25(11):2952-2964. (Mar 16).
63. Tohyama Y., Yamamura H. Complement-mediated phagocytosis-the role of Syk. IUBMB Life 2006, 58(5-6):304-308. (May-Jun).
64. Tooyama I., Kimura H., Akiyama H., McGeer P.L. Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease. Brain Res. 1990, 523(2):273-280.
65. Vaarmann A., Gandhi S., Gourine A.V., Abramov A.Y. Novel pathway for an old neurotransmitter: dopamine-induced neuronal calcium signalling via receptor-independent mechanisms. Cell Calcium 2010, 48(2-3):176-182. (Aug-Sep).
66. Velazquez P., Cribbs D.H., Poulos T.L., Tenner A.J. Aspartate residue 7 in amyloid beta-protein is critical for classical complement pathway activation: implications for Alzheimer's disease pathogenesis. Nat. Med. 1997, 3(1):77-79. (Jan).
67. Wang W., Ji P., Dow K.E. Corticotropin-releasing hormone induces proliferation and TNF-alpha release in cultured rat microglia via MAP kinase signalling pathways. J. Neurochem. 2003, 84(1):189-195. (Jan).
68. Xaus J., Comalada M., Valledor A.F., Lloberas J., López-Soriano F., Argilés J.M., Bogdan C., Celada A. LPS induces apoptosis in macrophages mostly through the autocrine production of TNF-alpha. Blood 2000, 95(12):3823-3831. (Jun 15).
69. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 1996, 382(6593):685-691. (Aug 22).